tetano
Editor, Senior Moderator
Cells
. 2021 Jan 7;10(1):E91.
doi: 10.3390/cells10010091.
Experimental Models to Study COVID-19 Effect in Stem Cells
Rishi Man Chugh[SUP] 1 [/SUP], Payel Bhanja[SUP] 1 [/SUP], Andrew Norris[SUP] 2 3 [/SUP], Subhrajit Saha[SUP] 1 4 [/SUP]
Affiliations
Abstract
The new strain of coronavirus (severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2)) emerged in 2019 and hence is often referred to as coronavirus disease 2019 (COVID-19). This disease causes hypoxic respiratory failure and acute respiratory distress syndrome (ARDS), and is considered as the cause of a global pandemic. Very limited reports in addition to ex vivo model systems are available to understand the mechanism of action of this virus, which can be used for testing of any drug efficacy against virus infectivity. COVID-19 induces tissue stem cell loss, resulting inhibition of epithelial repair followed by inflammatory fibrotic consequences. Development of clinically relevant models is important to examine the impact of the COVID-19 virus in tissue stem cells among different organs. In this review, we discuss ex vivo experimental models available to study the effect of COVID-19 on tissue stem cells.
Keywords: COVID-19; SARS-CoV-2; organoid system; stem cells.
. 2021 Jan 7;10(1):E91.
doi: 10.3390/cells10010091.
Experimental Models to Study COVID-19 Effect in Stem Cells
Rishi Man Chugh[SUP] 1 [/SUP], Payel Bhanja[SUP] 1 [/SUP], Andrew Norris[SUP] 2 3 [/SUP], Subhrajit Saha[SUP] 1 4 [/SUP]
Affiliations
- PMID: 33430424
- DOI: 10.3390/cells10010091
Abstract
The new strain of coronavirus (severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2)) emerged in 2019 and hence is often referred to as coronavirus disease 2019 (COVID-19). This disease causes hypoxic respiratory failure and acute respiratory distress syndrome (ARDS), and is considered as the cause of a global pandemic. Very limited reports in addition to ex vivo model systems are available to understand the mechanism of action of this virus, which can be used for testing of any drug efficacy against virus infectivity. COVID-19 induces tissue stem cell loss, resulting inhibition of epithelial repair followed by inflammatory fibrotic consequences. Development of clinically relevant models is important to examine the impact of the COVID-19 virus in tissue stem cells among different organs. In this review, we discuss ex vivo experimental models available to study the effect of COVID-19 on tissue stem cells.
Keywords: COVID-19; SARS-CoV-2; organoid system; stem cells.